IL2 and malignant colon neoplasm: Furthermore, we characterized the synthesized radiotracer in vitro and in vivo and assessed the efficacy of [18F]FB-IL-2 as an imaging biomarker in preclinical PET imaging of CD25+ TILs in syngeneic murine colon cancer models.